Key Market Indicators
Sales of Slovene digestive system disorder medicine are set to reach $77.5 million by 2026, an increase of 0.6 percent annually on average. Since 2012, the Slovene market has grown 3.8 percent per year. In 2021, the country ranked 23rd worldwide, with New Zealand ahead of it at $74.9 million. Japan, South Korea and Canada took the next three spots in the ranking, respectively.
